New FWF grant on NLRP3 signaling in AML awarded to CCS member Jutta Horejs-Hoeck
We are pleased to announce that the FWF approved in its latest meeting the project proposal of Jutta Horejs-Hoeck to investigate the function of NLRP3/EIF2 signaling in Acute Myeloid Leukemia patients. The work will be performed in close collaboration with the Cancer Cluster Salzburg groups of Prof. Richard Greil, Fritz Aberger, Daniel Neureiter and Christian Huber. Congratulations and good luck!